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Available online xxxxThere is a need to interpret in vitro concentration-viability data in terms of the actual concentration that the cells
are exposed to, rather than the nominal concentration applied to the test system.We have developed a process-
based model to simulate the kinetics and dynamics of a chemical compound in cell-based in vitro assays. In the
present paper we describe the mathematical equations governing this model as well as the parameters that
are needed to run the model. The Virtual Cell Based Assay (VCBA) is an integrated model composed of: [1] a
fate and transport model; [2] a cell partitioning model; [3] a cell growth and division model; [4] a toxicity and
effects model; [5] the experimental set up. The purpose of the VCBA is to simulate the medium and intracellular
concentrations, which can be used on its own to design and interpret in vitro experiments, and in combination
with physiologically based kinetic (PBK) models to perform in vitro to in vivo extrapolation. The results can be
used in chemical risk assessment to link an external dose to an internal effect or vice versa, using solely in vitro
and in silico tools and thereby avoiding animal testing.
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IVIVE1. Introduction
The hazard assessment of chemicals has traditionally relied on ani-
mal models, with protocols that have been standardized over the past
few decades (OECD, 1993; SCHER, Scientiﬁc Committee on Health and
Environmental Risks et al., 2013), and on the application of assessment
factors (AFs) to take into account uncertainties associated with the ex-
trapolation of animal model results to humans. However, integrated
testing strategies (ITS), more recently called Integrated Approaches to
Testing and Assessment (IATA), have gained increasing interest in toxi-
cology (van Leeuwen, et al., 2007;Worth & Patlewicz, 2016) due to new
in vitro and in silico technologies and methods becoming available, to
new knowledge generated (web databases), to new insights on the
mechanisms of toxic effects (Waters et al., 2003; Heijne et al., 2005;
NRC, 2007), and to increasing pressure from society and legislation to
avoid animal testing.
ITS/IATA assume that a combination of techniques can be applied to
assess chemicalswhile replacing, or at least reducing, the use of animals.
These techniquesmay include (DeJongh et al., 1999; Gubbels-vanHal et
al., 2005) read-across, chemical categories, (quantitative) structure ac-
tivity relationships ((Q)SAR), physiologically based kinetic models
(PBK1) and in vitro assays. In addition, it is now becoming widelyt Research Centre, Directorate F
afety and Alternative Methods
or PB(T)K standing for pharma-
td. This is an open access article und
t al., Theoretical andmathema
iv.2016.07.013accepted that to progress our understanding of chemical-induced toxic-
ity we must try to understand toxic mechanisms at the molecular level
and howmolecular changes relate to functional changes at higher levels
of biological organization (U.S. EPA, 2003). The research area devoted to
the understanding of the distribution of chemicals at the subcellular
level of biosystems, in terms of their properties has been called struc-
ture-based subcellular pharmacokinetics (SBSP). The main goal of
SBSP is a model-based description of the kinetics of the distribution of
chemicals, in terms of the properties of both chemicals and biosystems
(Balaz, 2009). Finally, the incorporation of functional genomics technol-
ogies in toxicology, such as the measurement of gene expression (tran-
scriptomics), protein levels (proteomics) or metabolite contents
(metabolomics), can also be considered when developing ITS/IATA.
Theﬁrst attempts to assess the applicability of ITS for the safety eval-
uation of chemicals (DeJongh et al., 1999; Gubbels-van Hal et al., 2005)
were based on the following elements:
- in vitro/QSAR data on ADME (Absorption, Distribution, Metabolism,
Excretion)
- PBK modelling (rat, human, etc.) using in vitro/QSAR data for calcu-
lating target tissue concentration in vivo for the prediction of dose-
response curves, NOEL (NoObserved Effect Level), LOEL (Lowest Ob-
served Effect Level), etc.
- in vitro and in vivo studies to validate the approach.
The application of this approach to a small set of ten substances fol-
lowing REACH requirements at production levels N10 ton showed that
it was possible to reduce by 38% the number of animals used, but furtherer the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 2. Schematic representation of the chemical partitioning in the cellular compartments
(adapted from Zaldívar et al., 2012).
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Concerning in vitro tests, the suggested reﬁnement (Gubbels-van Hal
et al., 2005) included the need to estimate the partitioning and bioavail-
ability of the chemical in the assay to improve the extrapolation from in
vitro toxic concentrations to in vivo target tissue concentrations.
In vitro cell based High Throughput Screening (HTS) consists of the
use of plastic tissue culture (TC) plateswith 96wellswhere amonolayer
of cells in a culture medium with serum is placed and then exposed to
the selected dissolved chemicals at several concentration levels
(Bouhifd et al., 2008). Even though in vitro assays are essential to eluci-
date toxic mechanisms of action, there are still several problems that
need to be solved before they are useful for ﬁlling data gaps on the haz-
ards of chemicals. These include the large inter-assay variability, the low
sensitivity and the differences found between in vitro and in vivo exper-
iments in terms of false positives and negatives (Höfer et al., 2004;
Lilienblum et al., 2008). To partially overcome the latter problem we
can improve in vitro toxicity testing by building a mathematical model
comprising the fate of a compound in the cell-based assay, that is, its
partitioning between the plastic wall, serum proteins/lipids and the
cell medium, and potentially the compound dynamics within the cell;
combined with a cell growth model. These processes together will
allow us to model the true concentrations causing perturbations in
cells given the nominal concentrations applied in a microtiter plate/
multiple well plate. With this aim in mind, the Virtual Cell Based
Assay (VCBA) was developed and implemented as a process-based
model derived from HTS laboratory data (Zaldívar et al., 2010;
Zaldívar and Baraibar, 2011). The VCBA can be regarded as amathemat-
ical representation of an in vitro assay to simulate the fate and effects of
a chemical. The VCBA model consists of ordinary differential equations
whose solution allows the calculation over time of the dissolved con-
centration of a chemical in cell culture aswell as the internal concentra-
tion in the cells. The VCBA model comprises:
[1] A fate and transport model that calculates the time-dependent
chemical concentration in the medium as well as in the headspace. This
takes into consideration a series of processes including evaporation,
partitioning of chemicals from the dissolved phase to serum proteins
and lipids, adsorption onto the plastic, and also degradation andmetab-
olism (Fig. 1).
[2] A cell partitioning model built on the assumption that once the
chemical is taken up by the cell, a partitioning occurs between three
compartments: one aqueous fraction and two non-aqueous fractions
corresponding to structural components (proteins) and energy re-
sources (lipids), Fig. 2.
[3] A cell growth and division model based on a four stage based
approach, with each stage corresponding to one of the four cell cycle
phases: G1, S, G2 and M, Fig. 3.
[4] A toxicity and effects model. The direct effects of a chemical
concentration, C, on cell dynamics (survival/mortality) are expressed
in terms of a cell killing rate, kr, and a no effect concentration, NEC,with-
in the cell.Fig. 1. Schematic representation of the fate and transport model part of the Virtual Cell
Based Assay (VCBA).
Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013[5] Details of the experimental set up that describe the surface, area,
size and shape of the well or well-plate.
The literaturewas screened toﬁndother similarmodels as theVCBA.
It was found that several research groups develop similar models,
Table 1, brieﬂy lists several works that incorporate similar modelling
approaches as the VCBA. The approach developed by Kramer (2010)
was used as the basis of the current VCBA.
This review explains the important aspects of the VCBA in a trans-
parent and clear (step by step) way. A detailed description is given of
the mathematical equations forming the different models that collec-
tively make up the VCBA. Furthermore, the calculation methods for
the relevant input parameters are also elucidated.2. Mathematical description of the Virtual Cell Based Assay
2.1. The fate and transport model
The fate and transport model consists of a dynamic mass balance
that includes a time-variable chemical transport and fate model for cal-
culating the chemical concentration in the medium as well as in the
headspace above the medium. This gas phase is included to eventually
allow consideration of the possible losses and cross contamination be-
tween the wells in the tissue culture (TC) plates, since the TC are not
hermetically sealed even though the system is generally designed to
minimize this aspect. However, to quantify this phenomenon, there
are not enough experimental data at the moment. Assuming two basic
compartments, i.e. a well-mixed medium compartment and a head-
space compartment and the sorption processes being fast compared
with the other processes, the mass balance equations for both compart-
ments can be written as follows:Fig. 3. Cell growth, G1, S, G2, M representation.
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Table 1
List of published references which characterize the fate of a chemical in in vitro cell lines.
Model Cell type Test Compound Exposures Details Reference
Three compartment [cell, medium,
protein] + effect
Primary rat hepatocytes,
Primary human
hepatocytes, HepaRG.
Ibuprofen Single,
Repeat
Kinetics,
Dynamicsa
Truisi et al. (2015)
Three compartment [cells, plastic and
medium]
The RTgill-W1 cell line was
obtained from rainbow
trout (Oncorhynchus
mykiss) gills.
Imidacloprid, Dimethoate, Carbendazim, Malathion,
Cyproconazole, Propiconazole, Pentachlorophenol,
Cypermethrin, 1,2,3-Trichlorobenzene, Naphthalene,
Hexachlorobenzene
Single kinetics Stadnicka-Michalak
et al. (2014)
Three compartment [head Space,
medium + sub compartment Serum,
plastic, DMSO, dissolved organic
matter, and cells/tissue]
Any Any Single Kinetics Armitage et al.
(2014)
Two compartment [medium, cell] + sub
compartment metabolism via clearance
Primary rat hepatocytes,
Primary human
hepatocytes,
HepaRG.
CPZ Single,
Repeat
Kinetics Broeders et al.
(2014)
Five compartment model: [air, medium,
protein, plastic, cell] + effect
Balb/c 3 T3, Mice.
RTgill-W1 cell line
rainbow trout
(Oncorhynchus mykiss)
gills.
Phenanthrene Single Kinetics,
Dynamicsa
Kramer et al.
(2012)
Five compartment model: [air, medium,
protein, plastic, cell] + effect
rainbow trout
(Oncorhynchus mykiss)
cell lines RTL-W1 and
RTgill-W1
benzo(a)pyrene, 1,2-dichlorobenzene, and
1,2,4-trichlorobenzene
Repeat Kinetics,
Dynamicsa
Kramer (2010)
Two compartment model [medium, cell] Human embryonal kidney
293 (HEK293).
[3H]estradiol,
octylphenol.
Single Kinetics Heringa et al.
(2004)
Three compartment [cells, culture
medium and culture vessel]
sperm cells. Antimycin A, digitonin, thioridazine HCl,
hexachlorophene 4,4′-DDE, dieldrin,
pentachlorophenol, methylmercury, chloride and
xylene and 1-nitronaphthalene
Single Kinetics Gülden et al.
(2001)
a Cell viability is the dynamic endpoint measured.
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VM
dCTot
dt
¼ AS  FAW−K deg  VMCdis ð1Þ
where VM refers to the volume of themedium (m3) and CTot refers to
the total concentration (mol m−3, equivalent to mmol l−1) in medium;
the ﬁrst term of the equation represents the transfer of chemical across
the air-water interface area (AS) with FAW the diffusive air-water ex-
change ﬂux; whereas the second term represents the transformation/
losses from the medium, e.g. degradation, decomposition, with Kdeg
the degradation rate in the medium, Cdis the dissolved concentration
in the medium (also as mol m−3).
The second compartment is the headspace air above the medium.
The total mass in that compartment can be described as:
VH
dCAir
dt
¼−AS  FAW−Al  Fl−Kairdeg  VH  Cair ð2Þ
where VH refers to the headspace volume (m3, equivalent to 1000 l; the
ﬁrst term represents the transfer of chemical across the air-water inter-
face whereas the second term represents the losses from the headspace
due to gas exchange. Al is the headspace area and Fl is the gas exchange
ﬂux, which in this ﬁrst approach was set to zero. The third term repre-
sents transformation in the headspace, i.e. degradation, decomposition,
with Kdegair being the degradation rate in air.
To model the partitioning of an organic chemical in the medium
(Kramer, 2010), we can consider that the compounds are either purely
dissolved (Cdis), bound to the protein-serum in the culture medium
(CPSM), bound to the lipids in the culture medium (CL), or bound to
the (plastic/glass) surface of the culture vessel (CP). Therefore, the
total concentration of an organic contaminant in the medium, CTot, canPlease cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013be described by following equation:
CTot ¼ Cdis þ CPSM þ CL þ CP 
SM
VM
ð3Þ
where SM refers to the surface area of the well in contact with the
medium. The partitioning of the compound between the different
phases canbe expressed as a function of the total nominal concentration
in the well as:
Cdis ¼
CTot
1þ KPSM PSM½  þ KL L½  þ Kp  SMVM
ð4Þ
CPSM ¼ KPSM  PSM½   CTot
1þ KPSM PSM½  þ KL L½  þ Kp  SMVM
ð5Þ
CL ¼ KL  L½   CTot
1þ KPSM PSM½  þ KL L½  þ Kp  SMVM
ð6Þ
CP ¼ KP  CTot
1þ KPSM PSM½  þ KL L½  þ Kp  SMVM
ð7Þ
The distribution of an organic compound is bymeans of the partition
coefﬁcients Ki, deﬁned as the relationships between the concentration
in a particular medium and in water (in m3 mol−1). In this case we
need to calculate the following partition coefﬁcients for protein-serum
[PSM], lipids [L], and plastic [P]:
Serum protein partition coefﬁcient KPSM (m3 mol−1 protein)
KPSM ¼ CPSM= PSM½ Cdis
ð8Þtical foundation of the Virtual Cell Based Assay – A review, Toxicology
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(mol protein m−3).
Lipid partition coefﬁcient, KL (m−3 kg lipid)
KL ¼
CL
L½ 
Cdis
ð9Þ
with [L] represents the concentration of lipids in the medium
(kg lipid m−3).
Plastic partition coefﬁcient, KP (m):
KP ¼ CPCdis
ð10Þ
where CP (mol m−2) is the concentration that binds to the plastic of the
well.
2.1.1. Estimation of the chemical partitioning inside the well
Within the model, each partition coefﬁcient is calculated by means
of QSARs. For serum protein partitioning, Kramer (2010) found the fol-
lowing correlation studying Polycyclic Aromatic Hydrocarbons (PAHs):
logKPSM ¼ 0:37  0:03ð Þ logKOW−0:29 0:12ð Þ ð11Þ
In a compilation of blood protein (albumin) data, DeBruyn and
Gobas (2007) found that, for different tissues, the sorptive capacity of
protein in solid animal tissues was higher than Kow for low Kow
chemicals (−1.3 ≤ log Kow ≤ 2) with a value around 1.31(±0.62)
(ml g−1 albumin). For higher Kow chemicals (2 b log Kow ≤ 5.1) the log-
arithm of the partition constant increased with log Kow following: 0.57
log Kow+0.69, whereas at higher Kow approached the lipid equivalence
value of 0.05, i.e. log Kow-1.3. In addition, they recommended, formodel-
ling purposes, to estimate the sorptive capacity of animal protein as 5%
that of lipid.
For the partitioning to lipids, Jonker and van der Heijden (2007)
found for Polycyclic Aromatic Hydrocarbons (PAHs) a linear correlation
between the lipid-water partition coefﬁcient and the octanol water par-
tition coefﬁcient as:
logKL ¼ 1:25  0:06ð Þ logKOW−3:70 0:37ð Þ ð12Þ
The amount of lipids in themedium [L] changes from an initial value
of 80 × 10−3 kg lipid m−3 (Gülden et al., 2001) to a value that depends
on the cell mortality, since the cell content goes back to the medium
once the cell dies. The correlation was used by Kramer (2010) to calcu-
late the partitioning of PAHs inmedium lipids. Similar correlations have
been found by other authors for different families of substances, but in
this work, we assume that this correlation holds for all the compounds.
For the partitioning to well plate plastic, Kramer (2010) found a lin-
ear correlation between Kp and Kow for the PAHs family.
logKP ¼ 0:97  0:15ð Þ logKOW−6:94 0:80ð Þ ð13Þ
As an example, if we consider a well with half of the liquid and a hy-
drophobic compound such as benzo[a]pyrene (log Kow= 6.13 and log
Kp = −0.99), 98% of benzo[a]pyrene binds to plastic. A similar
partitioning is known for amiodarone which has a high binding afﬁnity
to plastic. All these relationships presuppose that the compound has a
linear sorption isotherm which is normally a good approximation at
low concentrations. In addition, it is also assumed that there is no satu-
ration (plastic surface, protein binding sites, etc.) which may occur in
experiments at high doses. Furthermore, chemicals could evaporate
and move to the headspace compartment of the well and since the TC
plates are not hermetically closed they will diffuse to the other wells
during the experiment. The ﬁnal concentration will depend on the
physicochemical properties of the compound as well as on the appliedPlease cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013concentrations. As a ﬁrst approximation, we concentrate on simulating
the air-water exchange in a well assuming no transport outside takes
place. When experimental data becomes available, we will be able to
model the diffusion to other wells in the plate by introducing an ex-
change term in the mass balance. In this approach, the exchange be-
tween the headspace and the aqueous medium occurs through
diffusive gas exchange between the headspace and medium boundary
layer.
The diffusive air-water exchange ﬂux FAW (mol m−2 s−1) is repre-
sented as (Westerterp et al., 1984):
FAW ¼ KAW CairKGL−Cdis
 
ð14Þ
where Cair and Cdis are the gas-phase and the dissolved (liquid) concen-
trations (mol m−3), respectively. KGL is the dimensionless gas-liquid
partition coefﬁcient, and is calculated from the Henry's law constant
(H) using:
KGL ¼ HR  T ð15Þ
where R is the universal gas constant 8.314 10−3 kJ (mol·K)−1 and T is
the temperature (K). The temperature dependence of Henry's law con-
stant can be expressed as:
logH ¼ logH298 þ ΔHvap2:303  R
1
298
−
1
T
 
ð16Þ
where H298 is the Henry's law constant at 25 °C (Pa·m3 mol−1),
ΔHvap is the enthalpy of volatilization from water (kJ mol−1), which
have to be deﬁned for each chemical compound. The mass transfer co-
efﬁcient KAW (m s−1) is given by the following equation:
KAW ¼ 1KG  KGL þ
1
KL
 −1
ð17Þ
where KGL,KG andKL are themass transfer coefﬁcients (ms−1) in the
air and the water ﬁlms, respectively. The liquid phase mass transfer co-
efﬁcient, KL, is calculated from themass transfer coefﬁcient of CO2 in the
water side, (Kanwisher, 1963) which in the absence of ventilation (air
current) has a constant value: KLCO2 = 4.1 ∗ 10
−2(m s−1), by applying
a correction factor:
KL ¼ KLCO2
Sc
600
 −0:5
ð18Þ
where Sc is the Schmidt number of the chemical and 600 accounts
for the Schmidt number of CO2 at 298 K. The Schmidt number is deﬁned
as:
Sc ¼ μ
DL  ρ ð19Þ
where ρ and μ are the density and viscosity of the ﬂuid respectively
while DL is the coefﬁcient of molecular diffusion of the dissolved com-
pound (m2 s−1). The temperature dependence of the diffusion coefﬁ-
cient in water is calculated using the following correlation by Wilke
and Chang (1955):
DL ¼ 7:4  10
−12 α MWð Þ0:5
μ  V0:6b
 T ð20Þ
where T is the temperature of the solvent (in Kelvin (K)) and μ is its
viscosity (cP), Vb (cm3 mol−1) is the molar volume of the organic com-
pound at its normal boiling point, MW is the molecular weight
(g mol−1) of the solute and α is the association factor of the solvent,tical foundation of the Virtual Cell Based Assay – A review, Toxicology
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1984).
The gas phase mass transfer coefﬁcient, KG, is calculated using the
mass transfer coefﬁcient for water, which in the case of no ventilation
has a constant value: KG,H2O = 3 × 10−3 (m s−1), and then
KG ¼ KG;H2O DGDG;H2O
 0:67
ð21Þ
where DG and DG,H2O refer to the diffusion coefﬁcients in the gas
phase (air) of the chemical and water, respectively (Schwarzenbach et
al., 2003).
An empirical correlation that has been extensively used to estimate
the diffusion coefﬁcient in air, DG inm2 s−1, as a function of temperature
is the one presented in Fuller et al. (1966):
DG ¼
10−7  T1:75 MWairþMWBMWair MWB
 1=2
P
X
υð Þair
h i1=3
þ
X
υð ÞB
h i1=3 2 ð22Þ
where T is the temperature (K), P is the pressure (atm),MW are the
molecular weights (g mol−1) of air (28.8) and the organic compound,
and υ are the atomic diffusion values, ΣυAir = 20.1, that can be deter-
mined from the values in Table 2.
For the speciﬁc case of water in air, which is used after to calculate
the mass transfer coefﬁcient in the gas phase, we have adjusted the ex-
perimental values modifying the atomic diffusion values, i.e. Συwater =
10.8., then the diffusion coefﬁcient of water in air is calculated as:
DG,H2O = 1.2365 10−9 T1.75.
2.1.2. Degradation
In absence of detailed experimental data, degradation ﬂuxes
(mol s−1) are represented as a ﬁrst order reactions. Therefore for degra-
dation in the medium we have:
F deg ¼ kdeg  V deg  Cdis ð23Þ
where Cdis is the concentration of the contaminant in dissolved form
and kdeg is the degradation rate resulting from abiotic reactions such
as hydrolysis and photodegradation. A similar equation can be written
for the headspace:
FHdeg ¼ kairdeg  VH  Cair ð24Þ
Normally, when no detailed data are available, the degradation rate
kdeg is calculated from half-life times
kdeg ¼
ln2
t1=2
ð25Þ
In this work, we assessed the effects of considering the use of the
half-life values provided from the multimedia model installed in EPI
Suite v4.0.Table 2
Atomic diffusion volumes for use in estimating DG (Fuller et al., 1966).
C H O N Cl S Aromatic
ring
Heterocyclic
ring
Atomic diffusion
values
16.5 1.98 5.48 5.69 19.5 17.0 −20.2 −20.2
Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
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In the cell partitioning model we extrapolate the equation
concerning the cell model. The total number of moles of a compound
(ntot) in the cell can be divided as the sum in the different compartments
(Zaldívar et al., 2012, Zaldívar and Baraibar, 2011):
ntot ¼ naq þ nPSC þ nLC ¼ Vaq:Caq þ VPSC :CPSC þ VLC :CLC
  ð26Þ
where the Vi's refer to the compartment volumes (l) and the Ci's refer to
the concentrations in the compartments (mol·l−1), i.e. water, protein,
and lipid. Also the total number of moles of a chemical can be expressed
as:
ntot ¼ W:Cb=MW ð27Þ
where W is the cell weight (mass in g), MW is the molecular weight of
the chemical (g·mol−1) and Cb is the chemical concentration in the cell
(g·gww−1).
The chemical is assumed to be in equilibrium between the different
compartments with ﬁxed values of the partition coefﬁcients: KPSC
¼ CPSC=½PSCCaq and KLC ¼
CLC=½LC
Caq
.
The time evolution of this substance in the cell can be calculated by a
simplemass balance, assuming that the uptake and elimination rates rup
and rel (l·cm−2·s−1) are proportional to the surface area of the cell
(passive diffusion) and the transfer occurs through the aqueous com-
partment only as:
dntot
dt
¼ V2=3 rup:Cdis−rel:Caq
  ð28Þ
where Cdis and Caq refer to the chemical concentration (mol·l−1) out-
side of the cell and in the aqueous compartment of the cell (mol·l−1),
respectively. Appling the chain rule of differentiation to Eq. (27) we ob-
tain:
dntot
dt
¼ 1
MW
W
dCb
dt
þ Cb
dW
dt
 
ð29Þ
and rearranging terms we obtain:
dCb
dt
¼ MW:V
2=3
W
rup:Cdis−rel:Caq
 
−
Cb
W
dW
dt
ð30Þ
the last term represents thedilution due to growth of the cell. In the case
of non- proliferating cells this can be neglected.
Since the concentration in the aqueous fraction Caq is not a value that
is measured, then we have to convert in terms of Cb using the
partitioning approach. The wet weight, W can also be expressed as a
function of the volumes of the different compartments:
W ¼ ρ:V ¼ ρ Vaq þ VPSC þ VLC
  ð31Þ
On the other hand:
VPSC ¼ WPSC=ρPSC ð32Þ
VLC ¼ WLC=ρLC ð33Þ
Vaq ¼ Waq=ρaq ð34Þ
whereWPSC,WLC andWaq are themasses of proteins, lipids and aqueous
compartments in the cells and ρPSC, ρLC and aq their densities.
To ﬁnd the relation between Caq and Cb we have to combine ntot in
Eqs. (26)–(27), the partition coefﬁcients and Eqs. (32)–(33)–(34),tical foundation of the Virtual Cell Based Assay – A review, Toxicology
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Caq ¼ Cb
MW:
f aq
ρaq
þ f LC
ρLC
KLC LC½  þ f PSCρPSC
KPSC PSC½ 
 ! ð35Þ
where fi refer to themass fraction of each compartment (aqueous, lipid,
proteins) in the cell. Replacing this equation into Eq. (30) and
rearranging we obtain:
dCb
dt
¼ MW:V
2=3
W
rup
 !
Cdis−
V2=3
W:
f aq
ρaq
þ f LC
ρLC
KLC LC½  þ f PSCρPSC
KPSC PSC½ 
 ! rup
0
BBBB@
1
CCCCACb−
1
W
dW
dt
 
Cb
ð36Þ
However in this case uptake and elimination rates are not constant,
but dependon the status of the cell and take into account thedifferences
in growth. The variation of the wet weight,W, as a function of time can
be obtained, assuming constant composition and hence density, as:
dW
dt
¼ ρdV
dt
ð37Þ
If we consider spherical shapeA ¼ 43 πr2 and von Bertalanffy's growth
curve,
r tð Þ ¼ r∞− r∞−r0ð Þe−αGτ ð38Þ
where r0and r∞ refer to the initial and ﬁnal cell radius and αG is the von
Bertalanffy's growth rate. Then we have:
dV
dt
¼ 4  π r∞− r∞−r0ð Þ exp −αG  tð Þ½ 2 r∞−r0ð Þ  αG  exp −αG  tð Þ ð39Þ
However, the introduction of this term considers only a single cell
developing during the simulation. To consider the whole population of
the cells, instead of a single cell, we take average values for the weight,
its derivative, and the surface dependingon the four stages: G1, S, G2,M.
Themodel in Eq. (36) has several parameters that need to be evaluated.
The uptake and elimination rates, rup and rel, and the partition coefﬁ-
cients, KL and KP, depend on the compound; whereas the remaining pa-
rameters depend on the type of cell.
2.2.1. Chemical partitioning inside the cell: potential extension to include
metabolism
In principle, metabolism occurs inside the cell and, therefore, this
process is included in the chemical mass balance inside the cell. In any
case, we can assume the same principle and write:
Fmet ¼ Kmet  Cb ð40Þ
where Cb refers to the cell internal concentration (g gww−1) and kmet is
the metabolism rate constant (s−1). However, a better expression is
provided using the Michaelis-Menten equation:
Fmet ¼ V max  Cbkmet þ Cb
ð41Þ
where Vmax (s−1) represents themaximum rate achieved by the system
and kmet is the substrate concentration at which the reaction rate is half
of Vmax. Some cells are considered to be not metabolically competent
and in this case kmet = 0.
2.2.2. Estimation of the chemical partitioning inside the cell
A general approach to describe the distribution of an organic com-
pound is by means of the partition coefﬁcients, deﬁned as the relation-
ships between the concentration in a particular component – for the cellPlease cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013proteins and lipids- and in the aqueous component. In this casewe need
to calculateKPSC, andKLC. Several of these correlations have been found in
literature and all of them assume that the compound has a linear sorp-
tion isotherm which is normally a good approximation at low concen-
trations, i.e. there is no saturation.
2.2.3. Cell protein partitioning (KPSC)
The cell protein partitioning coefﬁcient can be expressed as:
KPMC ¼ CPSC= PSC½ Caq ð42Þ
where [PSC] is the concentration of proteins in the cell and the partition
coefﬁcient KPSC is expressed in m3·mol−1.
In a compilation of blood protein (albumin) data, DeBruyn and
Gobas (2007) found that, for different tissues, the sorptive capacity of
protein in solid animal tissues was higher than Kow for low log Kow
chemicals (−1.3 ≤ log Kow ≤ 1.09) with a value around 1.31(±0.62)
(ml g−1 albumin). For higher Kow chemicals (1.09 b log Kow ≤ 4.6) the
logarithm of the partition constant increased with log Kow following:
0.57 log Kow+ 0.69, whereas at higher Kow approached the lipid equiv-
alence value of 0.05, i.e. log Kow−1.3. Therefore, it is possible to write:
valp ¼
1:31  if  logKowb  1:09
0:57  logKow þ 0:69  if  ≤  logKow≤4:6
logKow−1:3  if  logKowN  4:6
8<
: ð44Þ
And then,
KPSC ¼ 10 valp−1:178ð Þ ð45Þ
where 1.178 is a factor to convertml g−1 albumin tom3mol−1 albumin.
AMW= 66,400 g mol−1 has been used for albumin. Where valp is the
log protein partition coefﬁcient in ml g−1 albumin.
2.2.4. Cell Lipid partitioning (KLC):
Thepartition coefﬁcient of a chemicalwith cell lipids, KLC, is deﬁned as:
KLC ¼
CLC
LC½ 
Caq
ð46Þ
where [LC] is the concentration of lipids in the cell (kg m−3).
As reported for Eq. 12, Jonker and van der Heijden (2007) found a
linear correlation for PAHs between the lipid-water partition coefﬁcient
and the octanol-water partition coefﬁcient as:
logKLC ¼ 1:25  0:06ð Þ logKOW−3:70 0:37ð Þ ð48Þ
This correlation was used by Kramer (2010) to calculate the
partitioning of PAHs in medium lipids. Similar correlations have been
found by other authors for different families of substances, but in this
work, we assume that this correlation holds for all the compounds.
2.2.5. Estimation of cell permeability
Assuming passive diffusion as the only transport mechanism, it is
possible to write (Del Vento and Dachs, 2002) that the uptake constant,
Kup (l g−1 d−1), is given by:
Kup ¼ p  Sp ð49Þ
where p (m d−1) is the cell permeability and Sp is the speciﬁc surface
area of cells (m2 kg−1), Sp = V2/3/W·p can be predicted as a function
of physicochemical properties of the molecule via several correlations.
In this work, we have used the experimental data obtained using
caco-2 cells by Yazdanian et al. (1998) to ﬁt an expression proposed in
USEPA (1992) as a function of the octanol-water partition coefﬁcienttical foundation of the Virtual Cell Based Assay – A review, Toxicology
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logp ¼−1:1711þ 0:98 logKOW−0:0011MW ð50Þ
where p is given in cm h−1; to convert it to m d−1 then:
p ¼ 0:24  10 −1:1711þ0:98 logKow−0:0011MWð Þ ð51Þ
On the other hand, combining Eq. 49 and the ﬁrst term in Eq. (36) it
is possible to obtain the relationship between cell permeability and up-
take rate. Combining Eq. 49 with Eq. 51 rup can be estimated as:
Kup ¼ V
2=3
W
 rup ð52Þ
rup ¼ 10p ð53Þ
where 10 is a factor to convert m d−1 to l·cm−2 d−1. In a similar way
the elimination constant, Kel (d−1) can be obtained as (Del Vento and
Dachs, 2002):
Kel ¼
p  Sp
BCF
ð54Þ
where BCF is the bio-concentration factor (l g−1) deﬁned as the ratio of
concentrations of the chemical in the cell and in water - freely dissolved
- at equilibrium. In addition, considering Eqs. (49) and (54) it can be ob-
served that the relationship between uptake and elimination constants
depends only on the bioconcentration factor. Furthermore, by compar-
ing Eq. (54) and the second rhs term in Eq. (36) it can be observed
that the uptake and elimination rates are equal, rup= rel. Furthermore
in our case the bioconcentration factor can be deﬁned as:
BCF ¼ f aq
ρaq
þ f LC
ρLC
KLC LC½  þ f PSCρPSC
KPSC PSC½ 
 !
ð55Þ
Table 6 summarises the estimated values for rup. These values were
used as initial parameters in the optimization procedure to ﬁt experi-
mental concentration-response curves.
2.3. Cell growth and division model
The model takes into account a cell growth and divisionwhich is a
four stepmechanism: G1, S, G2,M. In the stage-based type of modelling
the matrix AP, called Leslie matrix, which describes the transformation
of a cell population (nc= number of cells) from time t to time t + 1:
nctþ1 ¼ AP:nct ð56Þ
has the following structure:
AP ¼
P1 0 0 Fe
G1 P2 0 0
0 G2 P3 0
0 0 G3 P4
2
664
3
775 ð57Þ
where nct is a vector describing the cell population at each stage at time
t, Pi is the probability of surviving and staying in stage i, Gi is the proba-
bility of surviving and growing into the next stage and Fe is the cell di-
vision rate per unit time (h), i= 1,2,3,4.
The simple case of Fe being constant will lead to exponential cell
growth. Alternative a density – dependent term can be included in the
model to take into account that the cells stop dividing when they
reach conﬂuency, like formula (58), by linking Fe to the total number
of cells (independent of their stage), nctot, in the well (dwel; density inPlease cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013well):
Fe ¼ Fei exp: −nctot=dwelð Þ ð58Þ
Both Pi and Gi are functions of the survival probability pi and growth
probability γi:
Pi ¼ pi 1−γið Þ ð59Þ
Gi ¼ pi:γi ð60Þ
where
pi ¼ exp −zið Þ ð61Þ
and
γi ¼
1−pið Þpdi−1i
1−pdii
ð62Þ
where zi is the hourly instantaneousmortality rate and di is the duration
(h) of the i-th stage.
2.4. Toxicity and effects model
The effect of a chemical concentration, C, on the survival rate can be
integrated by expressing the mortality rate as
zi ¼ z0i þ kr Cb−NECð Þ⋯if⋯CbNNECz0i⋯if⋯Cb≤NEC⋯⋯⋯⋯⋯⋯⋯

ð63Þ
where Cb is the internal concentration of the toxicant in the cell, kr is the
killing rate and NEC is the no effect concentration term. This will modify
the terms Pi and Gi in the stage-based Leslie matrix. In principle, it is
possible to introduce a different expression for each cell stage. However,
for simplicity anddue to the fact that thedata to validate themodel does
not allow to distinguish this aspect, we have considered global (cell-
stage independent) kr and NEC values.
2.5. Experimental set up
The total volume of the well is given by assuming a truncated cone
equation:
VW ¼ 13π r
2 þ rRþ R2
 
h ð67Þ
The headspace volume (m3) is given by subtracting from the VW the
volume of the medium. The surface of the well in contact with the me-
dium,
SM ¼ π r þ rmð Þg þ Sbottom; ð68Þ
Where rm. is the radius of the occupied volume and g is the slant
height. The surface area of the cell-based assaymedium (As) is given by:
As ¼ π  r2m ð69Þ
The concentration response curves were ﬁtted using the biphasic
equations from Beckon et al. (2008):
y ¼ 1
1þ εup=x
 βup
 !
 1
1þ εdn=xð Þβdn
 !
ð65Þ
with βup N 0 and βdn b 0. Following Beckon et al. (2008) the β-values
represent the steepness, whereas β-values represent the dose at the
mid-point of the rising and falling phases, respectively. This approach
was introduced by Beckon et al. (2008) to consider biphasictical foundation of the Virtual Cell Based Assay – A review, Toxicology
Table 3
Physicochemical parameters used as input parameters in the VCBA model.
Chemical name Cas No. logKow MV (cm3 mol−1) ∑vB MW (g mol
−1) Water Deg. (s−1) Air Deg. (s−1) Henry
(Pa m3 mol−1)
Acetaminophen 103-90-2 0.46 159.98 146.27 151.17 5.35E−07 1.33E−05 6.51E−08
Verapamil hydrochloride 152-11-4 3.45 966.03 535.12 491.08 4.50E−08 9.00E−05 1.41E−09
Acetylsalicylic acid 50-78-2 1.19 178.06 166.06 180.16 5.35E−07 9.82E−07 0.000132
Maprotiline 10,262-69-8 4.52 347.31 300.43 277.41 2.14E−07 7.05E−05 0.00808
Cycloheximide 66-81-9 0.55 363.44 280.25 281.35 2.14E−07 4.91E−05 3.57E−10
Sodium lauryl sulfate 151-21-3 1.6 359.59 286.42 288.38 5.35E−07 1.11E−05 1.12E−10
tert-Butyl hydroperoxide 75-91-2 0.94 112.66 96.76 90.12 5.35E−07 2.25E−06 1.62
Valproic acid 99-66-1 2.75 194.78 174.64 144.22 5.35E−07 6.13E−06 0.304
Rifampin 13,292-46-1 4.24 850.96 811.86 822.96 4.50E−08 6.59E−04 2.75E−37
Thioridazine hydrochloride 130-61-0 4.93 375.85 384.04 407.04 1.34E−07 1.93E−04 9.56E−14
Amiodarone hydrochloride 19,774-82-4 7.57 523.1 447.45 645.32 4.50E−08 1.24E−04 1.82E−07
Caffeine 58-08-2 −0.07 206.06 133.74 194.19 5.35E−07 1.46E−05 3.63E−06
Colchicine 64-86-8 1.3 395.84 390.47 399.45 1.34E−07 6.98E−04 1.82E−12
Acrylamide 79-06-1 −0.67 80.92 70.57 71.08 5.35E−07 9.63E−06 0.000598
Diphenhydramine 58-73-1 3.27 298.91 292.85 255.36 2.14E−07 9.53E−05 0.000544
Pentachlorophenol 87-86-5 5.12 192.27 183.73 266.34 4.50E−08 4.13E−07 0.0127
Disopyramide 3737-09-05 2.58 420.11 380.38 339.48 4.50E−08 9.39E−05 2.62E−11
Chloroquine diphosphate 50-63-5 4.63 376.82 394.68 319.88 1.34E−07 1.13E−04 1.09E−07
Tetracycline hydrochloride 64-75-5 −3.7 457.57 406.42 482.92 1.34E−07 1.54E−04 1.27E−26
HPTE 2971-36-0 4.55 310.27 281.84 317.6 1440 0 3.05E−08
Pyraclostrobin 175,013-18-0 3.99 407.38 335.65 387.8 1440 0 5.31E−06
Diquat dibromide 85-00-7 −2.82 306.56 180.96 344.05 900 0 1.44E−08
Abamectin 71,751-41-2 4.4 2000.33 792 866.6 4320 0 0.0027
Bisphenol A 80-05-7 3.32 275.87 249.74 228.29 900 0 9.28E−07
Benomyl 17,804-35-2 2.12 324.06 265.44 290.32 360 0 1.25E−07
Table 4
Examples of cell line parameters for the 3 T3 Balb/c and A549 lung cell lines.
Parameter type Abbreviation
used in the
model
3 T3 Balb/c A549
lungs
Units
Mass fraction of
compartment fx
faq,
fL,
0.614
0.142
0.72
0.012 %
8 J.M.Z. Comenges et al. / Toxicology in Vitro xxx (2016) xxx–xxxrelationships in dose-response curves and it can be extended to consid-
er more than one positive and negative effect.
Finally the estimation of the killing rate and the no effect concentra-
tion is carried out by optimization analysis. In this case, we used esti-
mated values of rup and degradation rates (air and water half-life)
provided by EPI suite v4 (http://www.epa.gov/opptintr/exposure/
pubs/episuite.htm). The optimization error was calculated as:
error ¼
Xn exp
i¼1
ðviability exp−viabilitysimÞ2
¼
Xn exp
i¼1
ðviability exp−
ncð Þtot;t
ncð Þtot;t¼0
 !
sim
Þ2 ð66Þ
with viability deﬁned as the % of cells surviving at the end of the
experiment.
We used the constrained optimization procedurewith lower bounds
equal to zero as described in Zaldívar and Baraibar (2011). To improve
the minimization procedure, we started with the estimated values for
rup and kdeg and then we allowed them to change if the ﬁnal error was
decreasing.(aq-aqueous, L-lipids,
P-proteins)
fP 0.244
(Meisler, 1973)
0.268
(Poulin and
Krishnan,
1995)
weight
Initial cell radius
ﬁnal cell radius
von Bertalanffy's
growth rate
r0
r∞
αG
8.3057*10−6
6.592*10−6
1.2687*10−5
(Zaldívar et al.,
2010; Zaldívar
and Baraibar,
2011)
9.27*10−6
7.36*10−6
4.17*10−5
(Jiang et al.,
2010)
m
m
s−1
Density: Protein
Lipid
Aqueous
ρP
ρL
ρaq
1350
900
1000
1350
900
1000
g/l
g/l
g/l
Density cell type ρ 1073
(Zaldívar et al.,
2010; Zaldívar
and Baraibar,
2011)
1195
(Zaldívar
et al., 2012)
g/l3. VCBA model parameters
3.1. The fate and transport model: chemical properties
For the fate and transport model the following physicochemical
properties and parameters that depend on the compound needed to
be calculated to run the model and are described in Table 3. These pa-
rameters can be calculated with several in silico tools, EPI suite, QSAR
ToolBox etc. Henry constant, LogKow,MW, the air andwater degradation
were obtained from EPI suite v4.0 (experimental values were preferred
over predictions), the molecular volume at the boiling point –vB– was
calculated using the groupmethod from Schotte (1992) and the contri-
bution to the atomic diffusion volumes,, for use in estimating D by the
method of Fuller et al. (1966).Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.0133.2. The cell model parameters: mass fraction of compartments [protein,
lipids, water], partition coefﬁcients within the cell, uptake rate
The virtual cell (VC) model takes into account the fate of a com-
poundwithin a cell. The cell is divided in three compartments (aqueous,
lipids, and proteins). In Table 4 the relevant parameters for running the
model are listed with reference.
3.3. The cell growth model: information on cell cycle dynamics
Since we are interested in coupling this model with a cell cycle (CC)
model (e.g., Gérard andGoldbeter, 2009), themodelwas divided in four
stages (phases) - G1, S, G2, M- corresponding to the cell cycle to repre-
sent cell growth. The total duration was taken as 19 h (Zaldívar et al.,tical foundation of the Virtual Cell Based Assay – A review, Toxicology
Table 5
Examples of for cell growth parameters for the 3T3 Balb/c, A549 lung cells.
3T3 Balb/c
cell line
G1 S G2 M Reference
Duration (h),
Mortality(h−1)
Volume (m3)
Mass (g)
Initial cell
population (%)
Cell division
rate (h−1)
9.63
0.005
1.73 ∗
10−15
2.08 ∗
10−9
0.507
1026
3.65
0.005
2.4 ∗
10−15
2.4 ∗
10−9
0.192
3.45
0.04
2.4 ∗
10−15
2.4 ∗
10−9
0.181798
2.26
0.04
2.4 ∗
10−15
2.4 ∗
10−9
0.119202
Zaldívar et al. (2010)
Kudryavtsev et al.
(2004), Meisler (1973),
Frantz (1981)
Zaldívar et al. (2010)
Migita et al. (2010)
Optimized
A549 cell line G1 S G2 M Reference
Duration (h)
Mortality
(h−1)
Volume (m3)
mass (g)
Initial cell
population (%)
Cell division
rate (h−1)
7.37
1.62 ∗
10−4
1.67 ∗
10−15
1.79 ∗
10−9
0.1
0.9002
7.08
1.40 ∗
10−3
2.70 ∗
10−15
2.90 ∗
10−9
0.6
7.1
1.37 ∗
10−4
3.11 ∗
10−12
3.34 ∗
10−9
0.2
2.46
2.73 ∗
10−4
3.26 ∗
10−15
3.50 ∗
10−9
0.1
Zaldívar et al. (2012)
Optimized
Table 6
NEC, kr and uptake rate speciﬁc for cell line and compound.
Chemical
name
Cas No. NEC
(g gww−1)
kr (s−1) Errora rup (l cm−2
s−1)
3 T3 Balb/c
Acetaminophen 103–90-2 1.15 ∗ 10−3 2.20 0.039 3.61 ∗ 10−6
Verapamil
hydrochloride
152–11-4 7.44 ∗ 10−3 18.55 0.17 1.30 ∗ 10−3
Acetylsalicylic acid 50–78-2 2.34 ∗ 10−2 8.05 ∗
10−2
0.09 1.74 ∗ 10−5
Maprotiline 10,262–69-8 1.44 ∗ 10−3 147.11 0.03 2.49 ∗ 10−2
Cycloheximide 66–81-9 0 295.35 0.14 3.18 ∗ 10−6
Sodium lauryl
sulfate
151–21-3 8.24 ∗ 10−3 4.97 2.75 3.34 ∗ 10−5
tert-Butyl
hydroperoxide
75–91-2 4.86 ∗ 10−3 38.55 0.03 1.24 ∗ 10−5
Valproic acid 99–66-1 6.52 ∗ 10−2 0.0567 1.71 6.44 ∗ 10−4
Rifampin 13,292–46-1 1.897 ∗
10−2
1.16 1.15 3.30 ∗ 10−3
Thioridazine
hydrochloride
130–61-0 0.905 ∗
10−3
41.02 1.72 4.53 ∗ 10−2
Amiodarone
hydrochloride
19,774–82-4 2.943 ∗
10−3
5.173 0.11 9.58
Caffeine 58–08-2 6.944 ∗
10−3
0.285 0.05 9.78 ∗ 10−7
Colchicine 64–86-8 9.849 ∗
10−7
1.505 ∗
10−3
0.63 1.28 ∗ 10−5
Acrylamide 79–06-1 1.263 ∗
10−3
1.89 0.03 3.45 ∗ 10−7
Diphenhydramine 58–73-1 4.258 ∗
10−3
2.39 1.80 1.60 ∗ 10−3
Pentachlorophenol 87–86-5 1.893 ∗
10−3
3.38 1.99 9.94 ∗ 10−2
Disopyramide 3737–09-05 2.862 ∗
10−3
1.77 1.49 2.68 ∗ 10−4
Chloroquine
diphosphate
50–63-5 3.1967 ∗
10−4
24.66 0.15 2.87 ∗ 10−2
Tetracycline
hydrochloride
64–75-5 1.535 ∗
10−6
471.94 4 0.8 1.30 ∗ 10−10
A459
HPTE 2971–36-0 5 ∗ 10−7 27.91 12.97 –
Pyraclostrobin 175,013–18-0 0 7.64 – 6.14 ∗ 10−7
Diquat Dibromide 85–00-7 0 190.35 17.24 2.99 ∗ 10−12
Abamectin 71,751–41-2 2.5 ∗ 10−5 8.69 – –
Bisphenol A 80–05-7 2.32 ∗ 10−5 1.88 – –
Benomyl 17,804–35-2 7.29 ∗ 10−7 264.00 13.83 5.34 ∗ 10−11
a The error was calculated using the Eq. (66) (without multiplying for 100).
Table 7
Experimental settings information on the well plates (wp).
6 wp 12 wp 24 wp 48 wp 96 wp
Top internal
radius (m):
17.7·10−3 11.14·10−3 8.13·10−3 5.78·10−3 3.425·10−3
Bottom internal
diameter (m):
17.4·10−3 11.10·10−3 7.81·10−3 5.525·10−3 3.175·10−3
Depth (m): 17.4·10−3 17.53·10−3 17.4·10−3 17.4·10−3 10.76·10−3
Bottom area
(m2):
95·10−5 38.3·10−5 19.1·10−5 9.5·10−5 3.16·10–0.5
Volume of
medium (mL)
2.9 1.15 0.570 0.285 0.100
Volume of well
(mL)
16.8 6.9 1.9 0.95 0.36
Headspace
volume
(VH)(m3)
139·10−7. 57.5·10−7 1.33·10−7 0.665·10−7 2.6·10−7
9J.M.Z. Comenges et al. / Toxicology in Vitro xxx (2016) xxx–xxx2010) for 3 T3Balb/c and 24 h (Zaldívar et al., 2012) for A459. Cell divi-
sion rate (Fe) was considered as an optimization parameter. In Table 5
the parameters for cell growth needed to run the model for each cell
cycle step are reported.
3.4. The toxic effect model for NEC and killing rate kr
In order to optimize the model experimental curves, concentration
response curve are needed. Finally the model also features a
toxicodynamic effect model that takes into account mortality, by
means of cell viability. The mortality parameters of the cells due to
chemical effect are described by the NEC and kr. In Table 6, the NEC, kr
and uptake rate speciﬁc for cell line and compound are listed to give
an idea of the values needed to run this part of the VCBA.
3.5. The experimental set-up
The followingparameters areused todescribe the experimental set up:
• Incubator temperature (usually 37 °C);
• Type of plastic of the well plate;
• Amount of protein inmedium: Assuming a 5% (v/v) serum in theme-
dium, based on Fetal Bovine Serum, then [S]0 = 2.34 102 mol protein
m−3, if 10% [S]0 = 4.68 10−2 mol protein m−3 (Zaldívar et al., 2012)
The parameters used to describe the conﬁguration of the well plate
are listed in Table 7 were taken from supplier speciﬁcation fact sheet
(Corning Life Sciences), for each well a particular shape can be applied
and this can be corrected based on the well plate used.
3.5.1. Global estimation of parameters (uncertainties & assumptions)
To improve the parameter optimization, Zaldívar and Baraibar
(2011) performed an optimization analysis using several parameters,
rup, rel, kdeg, and kmet, in addition to kr and NEC, for which no values
were available. The results showed that as the number of parameters in-
creased, the optimization errors tend to decrease (Zaldívar and Baraibar,
2011). However, multiple minima where found which implies that the
concentration-response curves alone are not enough to elucidate
which is the best set of parameters to ﬁt the data. Thus, concentration
measurements become critical to validate the model. It is necessary to
anchor chemical concentrations with experimental data to be able to
obtain reliable model parameters.Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013The present model was built based on the following assumptions:
1. To estimate the partition coefﬁcients for lipid, serum, and plastic the
QSARs were optimized based on literature PAHs data (Zaldívar et al.,
2010; Zaldívar and Baraibar, 2011).tical foundation of the Virtual Cell Based Assay – A review, Toxicology
10 J.M.Z. Comenges et al. / Toxicology in Vitro xxx (2016) xxx–xxx2. Cell uptake is based on passive diffusion and no active diffusion is
considered.
3. Metabolism is not considered in the presentwork (kM=0) since the
cells are considered not metabolic competent.
4. The model is based on cells which are considered “happy” and does
not take into account stress factors such as wrong manipulation
from lab persons or bymould or viruses contaminations. No contam-
ination of factors which could inﬂuence in a negative way the cell
culture is taken into account.
5. Sensitivity analysis should be performed in order to understand the
uncertainty of the parameters on the result so the model can be op-
timized and reduced.3.5.2. The model code
The VCBA was built ﬁrst in Matlab, (Zaldívar et al., 2010, 2012;
Zaldívar and Baraibar, 2011) and was translated to R Language in
order to make it freely available for other users (the R code can be
found in the supplementary material). We have written the differential
equations describing the VCBAModel in R language and have integrated
them into the Knime environment through an R-KNIME node. In this
way the model is accessible to the user without need to modify it. The
differential equations describing the mass balance resulting from fate,
cell dynamics and toxicodynamics are solved by the DeSolve R package.
We have implemented the VCBA into a KNIME workﬂow in order to
have a user-friendly tool (Sala Benito et al., in this issue).Fig. 4. Simulation plot obtainedwith the Virtual Cell Based Assaymodel in 3T3 BALB/c cells. The
the headspace, and in the cell (Y-axis concentration of compound inM; X-Axis time in hours).
cells at time zero) versus time (in minutes).
Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.0133.5.3. Selected example of model output
Here we show one example of model output, represented by four
graphical representations. The simulation with the 3T3 BALB/c cells
originated from BALB/c mouse whole embryo cultures (Aaronson &
Todaro, 1968). They possess the ability to divide indeﬁnitely, but are
highly sensitive to the post-conﬂuence inhibition of cell division. The
cells grow in a monolayer without piling up, ceasing division when
they cover the dish surface. The VCBA model for this cell line takes
into account the growth (cell cycle) model: G1 – S – G2 – M.
Fig. 4 shows the VCBA simulation of the partitioning of the ex-
perimental concentration (Ctot). Starting clockwise from the top
left graph the concentration that is partitioning to the medium as
function of time. The applied concentration leads to evaporation
in the headspace (top right graph) and a certain amount is absorbed
within the cells (Cb). The absorbed part of the compound then im-
pacts the killing rate which (together with the cell division rate)
leads to a change in the number of cells over time (bottom right
graph in Fig. 4). In case the cell division rate is faster than the killing
rate this leads to an increased number of cells over time in the
system.
The results presented in Fig. 5 show3T3Balb/c viability simulation at
24 h exposed to increasing acetaminophen concentrations. The graph
reports the cell viability as a function of the intracellular and external
concentration in M. The intracellular concentration (Cint) in M was ob-
tained by converting the Cb (the intracellular concentration) in
g gww−1 to M by using the density of the 3T3 (1073 g/l) and the MWplot is concentration versus time, for the partitioning of acetaminophen in themedium, in
Furthermore we obtain the relative number of cells (viability normalized to the number of
tical foundation of the Virtual Cell Based Assay – A review, Toxicology
Fig. 5. Shows simulation of 3 T3 Balb/c viability versus increasing acetaminophen concentrations in intracellular and external experimental inM. Experimental data provides the observed
cell viability as a function of the concentration added to the well.
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CInt ¼ Cb  ρ
MW
Mð Þ:
Starting from the external concentration used to test chemical toxic-
ity in 3T3Balb/c, Table 8, tabulates the percentage of simulated concen-
tration after partitioning between the different models (headspace,
protein, plastic, and lipids) to obtain the concentration available to
enter the cell (dissolved column) starting from the concentration inme-
dium after 24 h (100%).
4. Discussion
In the present workwe have reviewed themathematical description
of the Virtual Cell Based Assay (VCBA). The VCBA is a set of mathemat-
ical equations and several input parameters are needed to run theTable 8
From the highest concentration (for each chemical) the percentage compared to the total conc
Chemical Medium Headspace
Acetaminophen 100 2.37E−09
Acetylsalicylic 100 4.76E−06
Acrylamide 100 2.18E−05
Amiodarone 100 8.87E−14
caffeine 100 1.96E−06
Chloroquine 100 1.62E−10
Colchicine 100 6.45E−14
Cyclohexamide 100 1.30E−11
Diphenhydramine 100 8.29E−06
Disopyramide 100 6.66E−13
Maprotiline 100 1.50E−05
Pentachlorophenol 100 5.48E−06
Rifampin 100 1.01E−39
Sodium lauryl 100 3.84E−12
tert-Butyl-hydroperoxide 100 0.059
Tetracycline 100 4.62E−28
Thioridazine 100 7.43E−17
Valproic acid 100 0.0070
Verapamil 100 1.71E−11
Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013model. The relevant parameters can be obtained by in vitro testing or
in silico predictions (such as QSAR). The VCBA comprises: [1] a fate
and transport model; [2] a cell partitioning model; [3] a cell growth
and division model; [4] a toxicity and effects model. [5] Parameters of
the experimental set up. The ﬁnal purpose of the VCBA is to simulate
the intracellular concentration and to derive chemical-speciﬁc
toxicodynamic parameters (No Effect Concentration and killing rate),
thereby separating in vitro kinetics from cell dynamics. The VCBA can
be used to design and interpret in vitro data and can be used in combi-
nation with physiologically based kinetic (PBK) models perform in
vitro to in vivo extrapolation.
The literature was searched to identify similar models which are
summarized in Table 1. The basis of the VCBA is the fate model which
was ﬁrst presented by Kramer (2010). Kramer's model takes into ac-
count the partition of a chemical through ﬁve phases in a closed system:
air, medium, protein, plastic, and cell. However, themodel does not take
into account cell population and cell growth. Furthermore, metabolismentration in the medium at 24 h for the 3T3 cell line.
Dissolved Proteins Lipids Plastic
94.01 5.96 5.64E−03 2.51E−02
93.08 6.75 0.05 0.13
94.03 5.96 2.18E−04 2.01E−03
0.0018 10.67 85.45 3.88
94.03 5.96 0.0012 0.0077
4.91 32.58 48.01 14.50
92.06 7.71 0.06 0.16
94.00 5.96 0.01 0.03
40.83 45.41 7.97 5.79
66.37 29.84 1.78 2.01
6.18 35.46 44.07 14.29
1.42 29.13 56.92 12.53
10.65 42.29 33.90 13.17
88.56 11.00 0.14 0.30
93.95 5.96 0.022 0.073
94.04 5.96 3.56E−08 2.31E−06
2.31 30.65 53.68 13.36
60.60 34.06 2.65 2.69
33.92 47.78 11.12 7.19
tical foundation of the Virtual Cell Based Assay – A review, Toxicology
12 J.M.Z. Comenges et al. / Toxicology in Vitro xxx (2016) xxx–xxxis also neglected in Kramer's study (Kramer, 2010; Kramer et al., 2012).
The VCBA includes metabolism, cell population and cell growth. Fur-
thermore, even though in this workwe have only consideredmodel op-
timization using the ﬁnal mortality effects, other readouts could also be
used for the optimization process, such asmitochondrialmembrane po-
tential and cell division rate.
Before Kramer (2010) a few models addressed the issue of chemical
partitioning (Heringa et al., 2004 and Gülden et al., 2001). After Kramer
(2010)moreworkwas devoted to the use in research and reﬁnement of
suchmodels (Truisi et al., 2015 and Stadnicka-Michalak et al., 2014). The
Broeders et al. (2014)model is based onmediumand cells and takes into
account metabolism of the parent compound. At the same time it is able
to simulate repeated exposure. The model was used to simulate the
biokinetic behaviour of the chlorpromazine (CPZ) inHepaRG test system
during a 14-days span. In a follow-up study (Broeders et al., 2015) the
model was applied to simulate CZP and diazepam under repeated expo-
sure conditions. The current VCBAwas described for use in a single expo-
sure mode; however, a repeated exposure mode like the one described
in both Kramer (2010) and Broeders et al. (2014) is addressed in a sec-
ond stage of the VCBA development (Paini et al., in this issue).
With a similar aim as the VCBA, to support in vitro test design and in-
terpretation of in vitro toxicity data, is amodel developed by Armitage et
al. (2014). In contrast to the VCBA model, the Armitage model was im-
plemented in Excel and includes partitioning of chemicals with DMSO
and interaction with dissolved organic matter which could have a
great effect in the distribution of the chemical in the test system.
Several assumptions were made when building the VCBA mode. To
estimate the partition coefﬁcients for lipid, serum, and plastic, QSARs
were derived based on literature PAHs data. The cell uptake is based
on passive diffusion and at present no active transport is considered.
Currently, it is considered that cells are not metabolic competent and
therefore the rate of metabolism kM is set equal to 0. No contamination
or other (e.g. cell handling) factors which could inﬂuence in a negative
way the cell culture is taken into account.
Even though we are able to simulate adequately experimental con-
centration-response data, the system is not completely observable –
for example, we cannot be certain that the simulated values of dissolved
and internal concentrations are completely correct. This should be fur-
ther tested using analytical chemistry measurements in the in vitro sys-
tems. However, the VCBAmodel shows that for the chemicals tested in
two cell lines we obtain good ﬁts of the concentration-response data
(Table 6) and the estimates for the NEC and kr (which are not directly
measurable) are obtained. The obtained values can be applied in simu-
lations of other exposure schemes (repeat exposure, acute, chronic). At
the same time, themodel is able to provide the evolution in time of con-
centrations absorbed by each compartment. Table 8 presents the ﬁnal
concentration in each compartment after 24 h of simulated exposure.
The toxic effect of a chemical is inﬂuenced by the concentration
absorbed in the cells.When only a small share of the chemical is actually
absorbed by the cells, a reduction of the toxicity effect is observed. As re-
ported in Table 8 the model allows the fate of the chemical in the well
and cell compartments to be simulated. As current in vitro experiments
are not capable of identifying the reason for a negative result (which
could be due to the fact that the chemical was not absorbed or because
it was absorbed and intrinsically non-toxic), the VCBA could provide
useful information to classify and reduce false negative predictions
that occur via testing in vitro.
The current version of the VCBA model is a ﬁrst step towards the
modelling of in vitro fate and intracellular concentrations as well as
cell dynamics. Some other features which the model could incorporate
are, for instance, simulation andprediction of other effects than cytotox-
icity, i.e. mitochondrial membrane potential (mmp), reactive oxygen
species (ROS) formation, caspase 3 activation and DNA binding. Fur-
thermore, the current model could be extended to include other types
of cell lines, i.e. HepG2, HepaRG, primary hepatocytes, cardiomyocytes,
kidney cells and neurons cells.Please cite this article as: Comenges, J.M.Z., et al., Theoretical andmathema
in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.07.013Future work will explore potential simpliﬁcation of the model. By
means of sensitivity analysis one can identify the impact of each and
every parameter on the variability of the output. This will allow us to
identify which parameters need to be estimated with high precision in
order to reduce the variability of the result.
This paper is the ﬁrst in a collection of papers on the theoretical
basis, development and possible uses of the VCBA. These papers de-
scribe: i) a new reﬁned VCBA for simulation of in vitro intracellular con-
centration; ii) the practical use of the VCAB in simulation of single
exposure in vitro scenarios in additional cell lines add and simulation
of repeated exposure in vitro scenarios in HepaRG; iii) the integration
of the VCBAwith PBKmodelling to support in vitro to in vivo extrapola-
tion; iv) an automated workﬂow for in silicomodelling of chemical fate
and toxicity; and ﬁnally (v) future perspectives on the integration of in
silico and in vitromodels for the regulatory assessment of chemicals.
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